McCourt Marion sold REGN
June 3, 2024 · Form 4 insider transaction
McCourt Marion sold 1,138 shares of Regeneron Pharmaceuticals, Inc. at $980.16 per share, a transaction worth $1.12M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,138
Price
$980.16
Total value
$1.12M
InsiderMcCourt Marion
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 3, 2024
Filing dateJune 5, 2024
Shares owned after12,931
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 13, 2024.